Predict your next investment

Corporate Venture
dayli.partners

See what CB Insights has to offer

Investments

35

Portfolio Exits

2

Funds

2

About DAYLI Partners

DAYLI Partners, part of DAYLI Financial Group, is a bio-focused venture capital firm that discovers, invests in, and supports science and technology.

DAYLI Partners Headquarter Location

Urban Hive Building 15th Floor 476, Gangnam-daero, Gangnam-gu

Seoul, 06120,

South Korea

+82)2-563-0890

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

DAYLI Partners Investments

35 Investments

DAYLI Partners has made 35 investments. Their latest investment was in MxT Biotech as part of their Series A on May 5, 2022.

CBI Logo

DAYLI Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/16/2022

Series A

MxT Biotech

$3.9M

Yes

1

4/5/2022

Series A - II

KCell Biosciences

$2.86M

Yes

1

2/23/2022

Series C

BIORCHESTRA

$45M

No

5

2/17/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/7/2022

Bridge

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/16/2022

4/5/2022

2/23/2022

2/17/2022

2/7/2022

Round

Series A

Series A - II

Series C

Series A

Bridge

Company

MxT Biotech

KCell Biosciences

BIORCHESTRA

Subscribe to see more

Subscribe to see more

Amount

$3.9M

$2.86M

$45M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

5

10

10

DAYLI Partners Portfolio Exits

2 Portfolio Exits

DAYLI Partners has 2 portfolio exits. Their latest portfolio exit was ViGenCell on August 01, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/1/2021

IPO

$99M

Public

1

6/17/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/1/2021

6/17/2020

Exit

IPO

IPO

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Public

Subscribe to see more

Sources

1

10

DAYLI Partners Fund History

2 Fund Histories

DAYLI Partners has 2 funds, including DAYLI Early Bird Bio-Health Care Fund No. 2.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/2/2021

DAYLI Early Bird Bio-Health Care Fund No. 2

$8.43M

1

7/2/2021

DAYLI Swanson Bio Healthcare Fund No. 7

$99M

10

Closing Date

7/2/2021

7/2/2021

Fund

DAYLI Early Bird Bio-Health Care Fund No. 2

DAYLI Swanson Bio Healthcare Fund No. 7

Fund Type

Status

Amount

$8.43M

$99M

Sources

1

10

DAYLI Partners Team

1 Team Member

DAYLI Partners has 1 team member, including current Chief Executive Officer, SeungHo Lee.

Name

Work History

Title

Status

SeungHo Lee

Chief Executive Officer

Current

Name

SeungHo Lee

Work History

Title

Chief Executive Officer

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.